The thoracic aorta consists of the aortic root, ascending aorta, aortic arch, and the descending aorta. An aneurysm occurs when the typical diameter of the artery increases by 50%. It occurs due to the intrinsic weakness of the aortic wall. Thoracic aortic aneurysms (TAA) rarely manifest with symptoms, and about 95% of the patients are asymptomatic. These aneurysms can lead to catastrophic complications, including aortic dissection or rupture, and are hence termed “silent killers.” About 22% of individuals die before reaching the hospital during an aneurysm complication. Most aneurysms in the thoracic aorta occur in the root or ascending aorta, followed by descending aorta and infrequently occur in the arch.
Male gender, increased age, history of hypertension, chronic obstructive pulmonary disease (COPD), coronary artery disease, smoking, and previous aortic dissection are risk factors of TAA. The distinct demarcation in causes for aortic aneurysms is the ligamentum arteriosum. Above this point, degenerative processes in the elastic media lead to the formation of aneurysms, and below the ligament, atherosclerosis is the perpetrator. This is probably due to the dissimilar embryonic derivation of the smooth muscle cells in these two regions. A family history of thoracic aortic aneurysm is a strong risk factor, as about 20% of cases of TAA are a consequence of genetic conditions. Only 5% of the patients have Marfan syndrome, Loeys-Deitz syndrome, and Ehlers-Danlos syndrome. About 21% of the patients with a family history are nonsyndromic, and these aneurysms are referred to as “nonsyndromic familial aortic aneurysm” and have no extra-aortic manifestations. Left-sided valvular endocarditis can rarely result in an aortic root dilation. Syphilis used to be the leading cause of aortic aneurysms before the advent of antibiotics. Arteritis, including Takayasu, Behcet, Giant cell, systemic lupus erythematosus, sarcoidosis, rheumatoid arthritis, and ankylosing spondylitis can involve the aorta in rare instances and result in an aneurysm. A bicuspid aortic valve and an isolated sinus of Valsalva aneurysm are also rare causes. There is a TAA association with an abdominal aortic aneurysm, intracranial aneurysm, renal cysts, and bovine aortic arch.
In the United States, about 13000 patients die because of the aortic disease each year, and TAA is the 18 most common cause of death among all individuals. TAA has an incidence of 10 cases per 100000 patient-years and a prevalence of 0.16 to 0.34%. The incidence of TAA is increasing due to better diagnostic imaging and increased life expectancy in the general population. Patients with familial TAA have an average age of presentation at 56.8 years, while patients with TAA due to other causes present around 64.3 years. More men develop TAA, while more women develop worse clinical outcomes and have an increased risk of dissection.
Both biochemical and mechanical factors lead to the formation of thoracic aortic aneurysms. The discrepancy between the wall structure elements including elastin and collagen, proteoglycans, and proteolytic and inflammatory mediators (transforming growth factor-B [TGF-B]) leads to wall weakness and expansion. Matrix metalloproteinases and cathepsins sever the extracellular matrix of the aortic media. This results in cystic medial degeneration. Changes in aortic wall compliance lead to increased stress on the wall as per Laplace’s law (tension= pressure x radius) during a systolic impulse and can further exacerbate wall weakness and lead to the formation of an aneurysm. Intimal atherosclerosis in the descending aorta can further exacerbate medial degeneration. Aortic ulcers, which are disrupted atherosclerotic plaques, and intramural hematoma, which are a collection of blood within the aortic wall, are also found in the descending aorta and can result in dissection or rupture. A mycotic aneurysm can occur due to an infection damaging an area in the aortic wall.
The ascending aorta contains three layers. The intimal layer consists of a single layer of endothelial cells. The medial layer is composed of elastin, smooth muscle cells, extracellular matrix, and collagen. An external layer of adventitial tissue is present, which also houses the nerves and vasa vasorum. In an aortic aneurysm, the elastic layer breaks up, and the smooth muscle cells become defective. In due course, a cystic appearing mucoid material replaces the contents of the medial layer, leaving behind the intima and adventitia only.
Almost all patients of thoracic aortic aneurysms are asymptomatic. Patients can report chest pain. If this pain radiates to the back with severe hypotension, it may be an alarming feature for dissection. Chest pain can also occur because of compression of adjacent structures. Some patients can present with difficulty breathing due to airway compression or with signs of superior vena cava (SVC) syndrome. Hoarseness of voice can occur due to the compression of the recurrent laryngeal nerve. In rare instances, ascending or root aneurysms can present with signs of heart failure due to rupture in the right atrium or superior vena cava (SVC), or with hemoptysis due to bleeding in the lung. Patients should be questioned about the history of sudden cardiac death in the family. On examination, most aneurysms are silent. In patients with aortic regurgitation, a diastolic murmur with widened pulse pressure would be noted. Patients should also be examined for physical signs of Marfan and Loeys Dietz syndromes to evaluate for the syndromic cause of aortic aneurysm.
A contrast-enhanced CT scan is the most widely used imaging technique to diagnose thoracic aortic aneurysms. It is readily available and aids in rapid assessment of the size, extent, and location of the aneurysm. Calcifications, dissections, and mural thrombus can also be clearly visualized. When prior CT scans are available, the current scan should be compared to the earliest scan and not the most recent scan.
MRI provides an axial and 3-D reconstruction of the ascending aorta. Contrast-enhanced MR angiography with gadolinium allows more accurate measurements of the aorta and its branches.
Transesophageal echocardiography (TEE) accurately diagnoses aortic aneurysms and dissections and is a reliable technique to measure the annulus, sinus, sinotubular junction, and the ascending dimensions. Transthoracic echocardiography (TTE) is a reliable test to check the aortic root and the severity of aortic regurgitation; however, the distal aorta would not be clearly visualized.
Ascending aortography can demonstrate crisp images of the aortic contour and loss of the typical “waist” of the sinotubular junction during an aneurysm evaluation, although size measurements cannot be made.
PET scans are a newer diagnostic test and can show areas that “light up,” indicating increased metabolic activity depicting inflammation, signifying impending rupture and should warrant prophylactic surgery.
A chest x-ray may show a convex contour of the right superior mediastinum, indicating an aortic aneurysm. In the lateral chest x-ray, there would be an absence of the retrosternal airspace in cases of an ascending aortic aneurysm.
Electrocardiogram (EKG) may demonstrate changes associated with aortic insufficiency, which would show signs of strain and left ventricular hypertrophy. Patients with concomitant coronary artery disease would show ST elevation or depression.
Genetic testing can now be employed to assess for TAA. Whole-exome and genome sequencing are effective in analyzing genes associated with thoracic aortic disease. Patients with high-risk genotypes, including MYLK, ACTA2, and MYH11 mutations, can be diagnosed efficiently.
Medical management aims at reducing stress in the aorta, which in turn prevents the growth of the aneurysm. Anti-impulse therapy is essential, and beta-blockers are the first-line drugs as they reduce stress by decreasing both blood pressure and contractility.  Angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors are beneficial for patients with Marfan syndrome as they reduce TGF-B signaling. Lipid-lowering agents, mainly statins, are also employed as they reduce oxidative stress, rate of rupture, and dissection. Glucocorticoids, indomethacin, and leukocyte-depleting antibody (anti-CD 18) can also be used. Fluoroquinolones should be avoided as they increase wall degeneration in patients with TAA. In asymptomatic patients, reimaging should be performed at 6 months and then annually if there is no expansion to monitor TAA progression. Lifestyle modification, including smoking cessation and diet to control hypertension, is advised.
Surgery in patients with TAA aims to prevent dissection or rupture of the aneurysm. Patients with acute dissection, rupture, or intramural hematoma need immediate surgical correction. There is an increased risk of rupture when the ascending aorta reaches 6 cm, and the descending aorta is at 7 cm. Therefore, elective surgery is advised for patients with a 5.5 cm ascending aorta and 6.5 cm descending aorta; the cut off for ascending aneurysm is 5 cm in an asymptomatic patient with Marfan syndrome. Body size is also taken into account while planning surgery where an aortic size index (aortic diameter divided by body surface area) less than 27.5 cm/m necessitates surgery. In TAA of the ascending aorta, an open surgical approach with aorta replacement is performed. The extent of resection depends on the location of aneurysmal disease: some patients may be sufficiently treated with supracoronary ascending aorta replacement alone, while others may need more extensive surgery, which may include the aortic root or aortic arch. For patients with connective tissue disorders, bicuspid aortic valve, or strong family history of aortic dissection or rupture, replacing the sinus segment, ascending aorta, and proximal arch may be beneficial. For a bicuspid aortic valve, the valve can be replaced or repaired at the time of aortic surgery. Open repair generally entails median sternotomy, cardiopulmonary bypass and ischemic arrest with or without deep hypothermic circulatory arrest (DHCA). For ascending aorta replacement alone, it is preferred to utilize DHCA with open distal anastomosis. After aortic cross-clamping and achieving cardioplegic arrest, the aorta is transected 1 cm below the clamp and resected to the sinotubular junction. Once the goal temperature is reached, a circulatory arrest is initiated, and the cross-clamp is released. The remainder of the ascending aorta is excised up to the base of the innominate artery takeoff. An appropriately sized polyester or Dacron tube graft is then anastomosed to the open aorta. Cardiopulmonary bypass is reinitiated, and the proximal anastomosis then performed to the sinotubular junction. Cerebral protection techniques, including antegrade or retrograde perfusion, can be employed. Branched arch grafts or debranching grafts can be used after the aortic arch is opened. Descending TAA is repaired with open repair, endovascular approach, or a hybrid procedure. These aneurysms are accessed via a thoracotomy in open repair and usually do not involve cardiopulmonary bypass or cardioplegia. Thoracic endovascular aortic repair (TEVAR) repairs TAA between the left subclavian and the celiac arteries with endovascular grafts. During the procedure, a carotid-subclavian bypass may be performed when the stent edge covers the left subclavian artery. Special care is taken in TEVAR to prevent spinal cord ischemia. Custom made branched and fenestrated grafts can be ordered for elective cases.
Aortic dissection presents with severe tearing chest pain radiating to the back. It is one of the complications of TAA because of increased stress and aortic wall weakness. A tear develops in the intima leading to the creation of true and false lumens. Patients can also present with hypotension, nausea, shortness of breath with a difference in blood pressure between the right and left arm. On chest X-ray widening of the cardiac silhouette could be seen. A CT scan will clearly show intimal flap and the lumens in the aortic wall. Emergent surgery is needed to fix the defect.
Thoracic aortic pseudoaneurysm is an aortic rupture contained by the thin layer of adventitia. They develop following trauma or due to erosion of an atherosclerotic ulcerated plaque. Patients can present with chest pain or deficits due to embolization. CT scanning and angiography can visualize this anomaly. Surgical repair is necessary to prevent aortic rupture.
Aortic intramural hematoma is a hematoma located in the medial layer of the aorta. Usually, no intimal tears are present. They can occur because of a penetrating atherosclerotic ulcer, or by thrombosis of the false lumen after a dissection. Surgical correction is required to restore the architecture of the aortic wall as the hematoma is also a precursor for aortic dissection.
Each year the ascending aortic aneurysm increases in size by 1mm while the descending aortic aneurysm grows up to 3 mm. As the size of the aorta reaches 6 cm, its distensibility declines, and it becomes a rigid tube where increased pressure results in increased stress on the aortic wall. Surgery should be planned for all symptomatic patients and asymptomatic patients with an increased size aneurysm. Among the patients who undergo elective surgical correction for TAA, the 5-year survival is 85%, while those who undergo emergency surgery have a 5-year survival 0f 37%.
Aortic dissection and rupture can happen as a result of an enlarging aortic aneurysm. The incidence of these complications is similar, at 3.5 per 100000 patient-years.  The chance of rupture is 34% when the ascending aortic aneurysm reaches 6 cm.  Acute emotion and high-intensity weight lifting can lead to acute aortic dissection or rupture due to high blood pressure levels up to 300 mmHg. Aortic dissection also reflects patterns of circadian and diurnal rhythm with increased incidence in winter and morning time, depicting times when blood pressure is the highest.
Surgical complications include bleeding, stroke, pulmonary dysfunction, myocardial dysfunction, and perioperative mortality. Patients have perioperative mortality of 28.6% during the repair of the descending aorta and 23.4% during the endovascular repair.
In an autopsy study in patients with sudden cardiac death, the TAA complications of dissection and rupture occur between 2% to 7.3%.
An aorta is a vessel that carries oxygenated blood from the heart up to the brain and then down to the rest of the body. The part of the aorta in the thorax is called thoracic aorta, and the part below it is called the abdominal aorta. An aneurysm of the thoracic aorta occurs when some part of the vessel is dilated compared to its original size. The ascending aortic aneurysm is the most common type and occurs at the junction between the heart and the aorta. The descending aortic aneurysm is the second most common type, and this occurs in the region of the thoracic aorta facing the legs. Most patients do not have any symptoms, but few patients can complain of pain in the chest or back, cough, or hoarseness. This is a serious condition as most patients do not have any initial symptoms and will develop severe chest pain that goes to the back when the layers of the aorta are tearing apart, which is called aortic dissection. Similar pain can also signify aortic rupture when the aortic aneurysm bursts open. These are the most likely complications of this condition. Male gender, smoking, history of uncontrolled blood pressure, and cholesterol levels are the main risk factors for the development of these aneurysms.
Patients with certain genetic diseases of the connective tissue are more likely to develop an aortic aneurysm in the ascending aorta. They should be routinely screened for the size of the aorta. If the physician suspects a thoracic aneurysm, the patient would be advised to undergo a CT scan to assess the dimensions of the aorta. If the size of the aneurysm is small, the physician will keep on monitoring it periodically. With a diagnosis of TAA, patients should not perform strenuous workouts or lift heavy weights, and learn to stay calm and avoid acute emotion as this can increase blood pressure in the vessel which can dissect or rupture the aorta. Patients who smoke should quit, and those with secondhand smoke exposure should avoid those settings. A bigger size of the aneurysm, rapidly increasing size or patients with symptoms will need surgery to fix the problem. Patients with a family history of sudden cardiac death and TAA should get themselves evaluated. Recently genetic testing has been offered to screen family members and should be utilized to know if other members have the same disease genes.
Coordination among emergency medicine, cardiology, and cardiac surgery is vital in order to follow patients with incidental findings of a thoracic aortic aneurysm. Those patients who do not require surgery urgently should be managed by internal medicine and cardiology to maintain adequate control of their blood pressure and lipid levels. Al these specialties should coordinate as an interprofessional team. Cardiovascular nurses coordinate the care of patients and provide education. Pharmacists review medications, check for interactions and inform patients about side effects. In cases where patients present with tearing chest pain to the emergency department, physicians should have a high suspicion for aortic dissection or rupture and should notify cardiac surgery immediately. Preliminary misdiagnosis in a health facility is serious and around 40% hence there should be routine training on early diagnosis and management of the complications of an aortic aneurysm. Interprofessional teamwork will result in improved patient outcomes, with reduced morbidity and mortality. [Level 5]
|||Salameh MJ,Black JH 3rd,Ratchford EV, Thoracic aortic aneurysm. Vascular medicine (London, England). 2018 Dec; [PubMed PMID: 30370834]|
|||Hiratzka LF,Bakris GL,Beckman JA,Bersin RM,Carr VF,Casey DE Jr,Eagle KA,Hermann LK,Isselbacher EM,Kazerooni EA,Kouchoukos NT,Lytle BW,Milewicz DM,Reich DL,Sen S,Shinn JA,Svensson LG,Williams DM, 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010 Apr 6; [PubMed PMID: 20233780]|
|||Elefteriades JA,Habel N,Sun W,Sang AX,Kuzmik GA, The aortic wall: four questions and insights. The Journal of thoracic and cardiovascular surgery. 2013 Mar; [PubMed PMID: 23410770]|
|||Ziganshin BA,Elefteriades JA, Treatment of Thoracic Aortic Aneurysm: Role of Earlier Intervention. Seminars in thoracic and cardiovascular surgery. 2015 Summer; [PubMed PMID: 26686439]|
|||Saeyeldin AA,Velasquez CA,Mahmood SUB,Brownstein AJ,Zafar MA,Ziganshin BA,Elefteriades JA, Thoracic aortic aneurysm: unlocking the [PubMed PMID: 29204794]|
|||Cheung K,Boodhwani M,Chan KL,Beauchesne L,Dick A,Coutinho T, Thoracic Aortic Aneurysm Growth: Role of Sex and Aneurysm Etiology. Journal of the American Heart Association. 2017 Feb 3; [PubMed PMID: 28159818]|
|||Danyi P,Elefteriades JA,Jovin IS, Medical therapy of thoracic aortic aneurysms. Trends in cardiovascular medicine. 2012 Oct; [PubMed PMID: 22906366]|
|||Elefteriades JA,Farkas EA, Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. Journal of the American College of Cardiology. 2010 Mar 2; [PubMed PMID: 20185035]|
|||Kuzmik GA,Sang AX,Elefteriades JA, Natural history of thoracic aortic aneurysms. Journal of vascular surgery. 2012 Aug; [PubMed PMID: 22840907]|
|||Ziganshin BA,Zafar MA,Elefteriades JA, Descending threshold for ascending aortic aneurysmectomy: Is it time for a [PubMed PMID: 30557953]|
|||Booher AM,Eagle KA, Diagnosis and management issues in thoracic aortic aneurysm. American heart journal. 2011 Jul; [PubMed PMID: 21742088]|
|||Avadhani SA,Martin-Doyle W,Shaikh AY,Pape LA, Predictors of ascending aortic dilation in bicuspid aortic valve disease: a five-year prospective study. The American journal of medicine. 2015 Jun; [PubMed PMID: 25644322]|
|||Elefteriades JA,Ziganshin BA, Paradigm for Detecting Silent Thoracic Aneurysm Disease. Seminars in thoracic and cardiovascular surgery. 2016 Winter; [PubMed PMID: 28417864]|
|||Davies RR,Gallo A,Coady MA,Tellides G,Botta DM,Burke B,Coe MP,Kopf GS,Elefteriades JA, Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. The Annals of thoracic surgery. 2006 Jan; [PubMed PMID: 16368358]|
|||Liu F,Huang L, Usefulness of ultrasound in the management of aortic dissection. Reviews in cardiovascular medicine. 2018 Sep 30; [PubMed PMID: 31054559]|
|||Chun AS,Elefteriades JA,Mukherjee SK, Medical treatment for thoracic aortic aneurysm - much more work to be done. Progress in cardiovascular diseases. 2013 Jul-Aug; [PubMed PMID: 23993243]|
|||Ziganshin BA,Elefteriades JA, Yale milestones in reading the playbook of thoracic aortic aneurysms. Connecticut medicine. 2012 Nov-Dec; [PubMed PMID: 23243760]|
|||Ziganshin BA,Elefteriades JA, Surgical management of thoracoabdominal aneurysms. Heart (British Cardiac Society). 2014 Oct; [PubMed PMID: 25092876]|
|||Koullias G,Modak R,Tranquilli M,Korkolis DP,Barash P,Elefteriades JA, Mechanical deterioration underlies malignant behavior of aneurysmal human ascending aorta. The Journal of thoracic and cardiovascular surgery. 2005 Sep; [PubMed PMID: 16153912]|